Lupus Low Disease Activity State Attainable in Lupus Nephritis
Independent association seen for complete or partial renal response and lupus low disease activity state with lupus nephritis relapse risk reduction
FDA Approves SetPoint Neuroimmune Modulation Device for Rheumatoid Arthritis
The implantable neurostimulation device activates the body's innate anti-inflammatory and immune-restorative pathways
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
Cognitive functional therapy, with or without biofeedback, more effective than usual care for chronic disabling low back pain
FDA Publishes Full Texts of Response Letters to Drug Applications
The goal is to improve public understanding of the FDA decision-making process
Novel Exercise May Aid Rheumatoid Arthritis Outcomes
Blood flow-restricted resistance training improves strength and physical performance while reducing perceived pain
Shorter-Form Messaging May Be Preferable for Trial Recruitment
Enrollment in DANFLU-2 trial was significantly more likely for those receiving single-page letter versus two-page letters
Health Care Expenditure Expected to Top GDP Growth 2024 to 2033
National health care expenditure growth expected to outpace GDP, resulting in a health share of GDP that reaches 20.3 percent by 2033
27.2 Million People of All Ages Uninsured in 2024 in the United States
Nonsignificant increase seen from 2023; 11.6 percent of adults aged 18 to 64 and 5.1 percent of children aged 0 to 17 were uninsured in 2024
Insurers Promise to Speed Up Delays in Health Care Approvals
FDA Offers Speedier Approvals to Drug Companies Aligning With ‘National Priorities’
Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications
